No Data
Investors who bought high-level pharmaceutical Funds have hope! More than 80% of products achieved positive returns in the first quarter, and recovering losses is promising.
① A total of 264 medical Funds had positive returns in the first quarter of this year, accounting for over 80%, with many Funds achieving returns exceeding 15% this year. ② The net value of medical Funds established in 2020 and 2021 is currently being repaired, and investors who entered at high levels are expected to break even.
TONGRENTANGCM (03613.HK) intends to confiscate unclaimed dividends.
Globefinance reported on March 28 that TONGRENTANGCM (03613.HK) announced that the final dividend of HKD 0.19 per ordinary share for the year ended December 31, 2017, which was declared on March 12, 2018, will be forfeited and returned to the company if it has not been claimed by April 30, 2025 (Wednesday).
TONGRENTANGCM (03613): Feng Li has been appointed as a member of the nomination committee.
TONGRENTANGCM (03613) issued an announcement that starting from March 28, 2025, the company's non-executive director Ms. Feng Li...
TONGRENTANGCM (03613) released its annual results, with shareholders' profit attributable amounting to 0.5 billion Hong Kong dollars, a decrease of 7.4% year-on-year.
TONGRENTANGCM (03613) released its annual performance results for the year ending December 31, 2024, with revenue of 1.612 billion...
TONGRENTANGCM: Annual Results Announcement For The Year Ended 31 December 2024
[Brokerage Focus] CITIC SEC: The integration of the Traditional Chinese Medicine Industry is accelerating, and the leading players are expected to strengthen their position.
Jinwu Financial News | CITIC SEC states that the price of Traditional Chinese Medicine materials has entered a downward channel, and improvements in industrial costs are worth anticipating. Starting in January 2025, Traditional Chinese Medicine companies will successively complete inventory clearance through channels, and numerous e-commerce activities will occur during the Spring Festival, with strong purchasing power among Consumers. The e-commerce platforms' sales of Pharmaceutical products generally achieve high year-on-year growth rates. Benefiting from policy support and the accelerated aging of the population, the bank expects that overall demand for Traditional Chinese Medicine will continue to improve in the future, with industry consolidation accelerating, and leading companies are likely to become stronger.